Literature DB >> 10868800

Mouse monoclonal antibodies to hepatitis B virus preS1 produced after immunization with recombinant preS1 peptide.

C J Ryu1, Y K Kim, H Hur, H S Kim, J M Oh, Y J Kang, H J Hong.   

Abstract

We have efficiently generated mouse monoclonal antibodies (MAbs), which bind specifically to amino acids 21-47 of the preS1 domain of hepatitis B virus (HBV) by immunizing mice with the preS1 peptide (amino acids, aa 1-56) conjugated to keyhole limpet hemocyanin. Hybridomas were screened by an indirect enzyme-linked immunosorbent assay (ELISA) using the purified preS1 peptide as a coated antigen. Eighteen positive hybridomas were selected and subjected to isotyping. Of these, 5 clones secreted immunoglobulin G (IgG) and 13 clones secreted IgM. Four (KR1, KR2, KR3, and KR4) of the 5 IgG MAbs bound to preS1 peptide (aa 21-47). Epitope mapping using bacterially expressed GST fusion proteins revealed that three clones (KR2, KR3, KR4) (IgG1, K) recognize aa 21-35, while KR1 (IgG2a, K) recognizes aa 35-47 of the preS1. These MAbs immunoprecipitated HBV particles, demonstrating that they bind to native HBV particles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868800     DOI: 10.1089/02724570050031248

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  6 in total

1.  Immunocapture enzyme-linked immunosorbent assay for assessment of in vitro potency of recombinant hepatitis B vaccines.

Authors:  Rajalakshmi Shanmugham; Nagarajan Thirumeni; Varaprasada Sankarashetty Rao; Vidyasagar Pitta; Saranyarevathy Kasthuri; Nagendrakumar Balasubramanian Singanallur; Rajendra Lingala; Lakshmi Narsu Mangamoori; Srinivasan Alwar Villuppanoor
Journal:  Clin Vaccine Immunol       Date:  2010-06-30

2.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.

Authors:  Jun Wei; Yu-Qin Wang; Zhi-Meng Lu; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.

Authors:  Hai-Jie Yang; Min Chen; Tong Cheng; Shui-Zhen He; Shao-Wei Li; Bao-Quan Guan; Zi-Heng Zhu; Ying Gu; Jun Zhang; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

5.  A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.

Authors:  Eung Suk Lee; Mun Sik Jeong; Rohit Singh; Juyeon Jung; Hyunho Yoon; Jeong Ki Min; Kyung Hyun Kim; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

6.  Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods.

Authors:  Heesu Chae; Seulki Cho; Munsik Jeong; Kiyoung Kwon; Dongwook Choi; Jaeyoung Lee; Woosuk Nam; Jisu Hong; Jiwoo Lee; Seonjoo Yoon; Hyojeong Hong
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.